The University of Chicago Header Logo

Connection

Justin P. Kline to Risk

Back to Details
This is a "connection" page, showing publications Justin P. Kline has written about Risk.
Justin P. Kline
Connection Strength
0.022
Risk
  1. Phase I-II study of clofarabine-melphalan-alemtuzumab conditioning for allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2012 Jun; 18(6):913-21.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.